IL-1β can be triggered by inflammatory signaling in multiple immune types and is an important factor and driver of tumor malignant evolution, therefore IL-1β blockade may be an important strategy to inhibit tumor growth and metastasis. This evidence concerns the gene IL1B and neoplasm.